Hangzhou Alltest Biotech Co. Ltd. A (688606) — Cash Flow Quality Index
Hangzhou Alltest Biotech Co. Ltd. A (688606) has a Cash Flow Quality Index of 0.96x as of September 2025. Operating cash flow of CN¥55.21 Million is below net income of CN¥57.80 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hangzhou Alltest Biotech Co. Ltd. A (688606) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hangzhou Alltest Biotech Co. Ltd. A Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Hangzhou Alltest Biotech Co. Ltd. A across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688606 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hangzhou Alltest Biotech Co. Ltd. A (2016–2025)
Year-by-year earnings quality comparison for Hangzhou Alltest Biotech Co. Ltd. A. For live market cap and the full company financial profile, see market cap of Hangzhou Alltest Biotech Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥206.59 Million | CN¥220.19 Million | ▼ -13.8% |
| 2024 | 1.09x | CN¥329.52 Million | CN¥302.91 Million | ▲ +692.0% |
| 2023 | 0.14x | CN¥24.76 Million | CN¥180.28 Million | ▼ -88.0% |
| 2022 | 1.15x | CN¥1.36 Billion | CN¥1.19 Billion | ▼ -4.8% |
| 2021 | 1.21x | CN¥923.87 Million | CN¥765.69 Million | ▲ +31.6% |
| 2020 | 0.92x | CN¥622.72 Million | CN¥679.23 Million | ▼ -21.5% |
| 2019 | 1.17x | CN¥91.53 Million | CN¥78.42 Million | ▲ +254.1% |
| 2018 | 0.33x | CN¥18.60 Million | CN¥56.43 Million | ▼ -43.5% |
| 2017 | 0.58x | CN¥19.99 Million | CN¥34.24 Million | ▲ +33.3% |
| 2016 | 0.44x | CN¥6.72 Million | CN¥15.33 Million | — |